Amplification of the MYC gene in immunoglobulin light chain (AL) amyloidosis
Open Access
- 25 December 2019
- journal article
- Published by Tenri Foundation, Tenri Institute of Medical Research in Tenri Medical Bulletin
- Vol. 22 (2) , 54-62
Abstract
We report a woman in her sixties who presented with cardiac involvement of immunoglobulin light chain (AL) amyloidosis, which was categorized into stage IV disease according to the revised Mayo clinic staging scheme. There were no myeloma-defining events at presentation. Although no M-protein was found in the serum, Bence-Jones protein κ was detected in the urine by immunofixation. The bone marrow showed hypocellularity but contained 25.6% plasma cells by examination of aspirate smears, and the cells exhibited cytoplasmic κ light chain restriction by flowcytometry and immunohistochemistry. Fluorescence in situ hybridization and G-banding revealed t(11;14)(q13;q32), leading to the generation of the CCND1-immunoglobulin heavy chain fusion gene. We obtained metaphase spreads that contained a homogeneous staining region on chromosome 8 at band q24, where multiple copies of the MYC gene were localized. However, the majority of interphase nuclei carried 2 or 3 copies of MYC and only occasional cells had four or more MYC signals, suggesting that MYC amplification occurred in a fraction of neoplastic cells. It is therefore possible that the MYC amplification represented intraclonal genetic heterogeneity and diverse subclones in terms of the copy number of MYC were present at presentation.Keywords
This publication has 16 references indexed in Scilit:
- Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myelomaBlood Advances, 2018
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- IMWG consensus on risk stratification in multiple myelomaLeukemia, 2013
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain MeasurementsJournal of Clinical Oncology, 2012
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trialLeukemia, 2011
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityBlood, 2008
- High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparationBritish Journal of Haematology, 2004
- Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisBritish Journal of Haematology, 2002
- Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisBlood, 2001